EP0732919A4 - Diphenyl-2-propenoate und homologe hiervon zur behandlung von erkrankungen, die mit leukotrien b4 verbunden sind - Google Patents

Diphenyl-2-propenoate und homologe hiervon zur behandlung von erkrankungen, die mit leukotrien b4 verbunden sind

Info

Publication number
EP0732919A4
EP0732919A4 EP95905321A EP95905321A EP0732919A4 EP 0732919 A4 EP0732919 A4 EP 0732919A4 EP 95905321 A EP95905321 A EP 95905321A EP 95905321 A EP95905321 A EP 95905321A EP 0732919 A4 EP0732919 A4 EP 0732919A4
Authority
EP
European Patent Office
Prior art keywords
propenoates
leukotriene
homologs
diphenyl
useful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP95905321A
Other languages
English (en)
French (fr)
Other versions
EP0732919A1 (de
Inventor
Robert A Daines
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of EP0732919A1 publication Critical patent/EP0732919A1/de
Publication of EP0732919A4 publication Critical patent/EP0732919A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/56—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
    • C07C317/46—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton the carbon skeleton being further substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/72—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction of compounds containing >C = O groups with the same or other compounds containing >C = O groups
    • C07C45/75—Reactions with formaldehyde

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
EP95905321A 1993-12-09 1994-12-05 Diphenyl-2-propenoate und homologe hiervon zur behandlung von erkrankungen, die mit leukotrien b4 verbunden sind Withdrawn EP0732919A4 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16460493A 1993-12-09 1993-12-09
US164604 1993-12-09
PCT/US1994/013966 WO1995015752A1 (en) 1993-12-09 1994-12-05 Diphenyl-2-propenoates and homologs thereof useful for treating diseases associated with leukotriene b4

Publications (2)

Publication Number Publication Date
EP0732919A1 EP0732919A1 (de) 1996-09-25
EP0732919A4 true EP0732919A4 (de) 1997-05-02

Family

ID=22595252

Family Applications (1)

Application Number Title Priority Date Filing Date
EP95905321A Withdrawn EP0732919A4 (de) 1993-12-09 1994-12-05 Diphenyl-2-propenoate und homologe hiervon zur behandlung von erkrankungen, die mit leukotrien b4 verbunden sind

Country Status (8)

Country Link
EP (1) EP0732919A4 (de)
JP (1) JPH09506366A (de)
CN (1) CN1139880A (de)
AU (1) AU1398395A (de)
CA (1) CA2178634A1 (de)
NZ (1) NZ278484A (de)
WO (1) WO1995015752A1 (de)
ZA (1) ZA949786B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6416733B1 (en) 1996-10-07 2002-07-09 Bristol-Myers Squibb Pharma Company Radiopharmaceuticals for imaging infection and inflammation
BRPI0906348A2 (pt) * 2008-04-11 2019-07-16 Inst Of Medicinal Molecular Designer Inc composto representado pela fórmula (1), composição farmacêutica; inibidor pai-1 e medicamento para prevenção para prevenção e/ou tratamento terapêutico de doença causada pela manifestação de pai-1 ou pelo aumento da ação de pai-1
US8633245B2 (en) 2008-04-11 2014-01-21 Institute Of Medicinal Molecular Design, Inc. PAI-1 inhibitor

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993010780A1 (en) * 1991-12-06 1993-06-10 Smithkline Beecham Corporation Heterocyclic-substituted pyridine compounds and uses
WO1994000437A1 (en) * 1992-06-30 1994-01-06 Smithkline Beecham Corporation Pharmaceutical pyridine compounds

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993010780A1 (en) * 1991-12-06 1993-06-10 Smithkline Beecham Corporation Heterocyclic-substituted pyridine compounds and uses
WO1994000437A1 (en) * 1992-06-30 1994-01-06 Smithkline Beecham Corporation Pharmaceutical pyridine compounds

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO9515752A1 *

Also Published As

Publication number Publication date
EP0732919A1 (de) 1996-09-25
CA2178634A1 (en) 1995-06-15
WO1995015752A1 (en) 1995-06-15
ZA949786B (en) 1995-10-11
AU1398395A (en) 1995-06-27
CN1139880A (zh) 1997-01-08
JPH09506366A (ja) 1997-06-24
NZ278484A (en) 1998-02-26

Similar Documents

Publication Publication Date Title
AU4861493A (en) Clear leave-on treatment composition and method
AU2187992A (en) Composition and method for disease treatment
GB2276639B (en) Solutions for wood treatment and their preparation
GB9406963D0 (en) Heaters and heated devices
ZA947138B (en) Skin care method and composition
EP0691550A3 (de) Polymerisierbare Zusammensetzung und organisches Glass
PH31600A (en) Methods of inhibiting atrophy of the skin and vagina.
EP0735894A4 (de) Zusammenseuzungen und methoden zur verbesserung der regeneration von neuralem gewebe
EP0705673A3 (de) Medizinische Gegenstand und Verfahren dafür
GB2281830B (en) I/q-modulator and i/q-demodulator
IL107763A0 (en) Infrared microscope
AU6210194A (en) Local heat treatment device and corresponding treatment method
EP0732919A4 (de) Diphenyl-2-propenoate und homologe hiervon zur behandlung von erkrankungen, die mit leukotrien b4 verbunden sind
EP0888780A4 (de) Zusammensetzung zur behandlung von kontaktlinsen und methode zur anwendung derselben
GB2277529B (en) Inorganic skin film and process for forming the same
GB9420539D0 (en) Process and composition
ZA916967B (en) Topical treatment and composition
ZA947139B (en) Skin care method and composition
AU7947794A (en) Azoospermia identification and treatment
HU913022D0 (en) Fibroplast increasing factor for treating and preventing virus caused diseases
GB9501907D0 (en) Allatostatins and their use
GB2292219B (en) Polymorphisms in human phosphoglucomutase-1
GB9310675D0 (en) Improved heated way cutter and cauteriser
GB9517735D0 (en) Thermal treatment
GB9306369D0 (en) Skin condititioning composition and method

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19960704

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: SI PAYMENT 960704

RAX Requested extension states of the european patent have changed

Free format text: SI PAYMENT 960704

A4 Supplementary search report drawn up and despatched

Effective date: 19970318

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19970620